Radnor, PA March 22, 2018
Airgas Healthcare Receives Innovative Technology Designation from Vizient for INTELLI-OX™
Airgas Healthcare, the specialized healthcare brand of Airgas, an Air Liquide company, announced that its INTELLI-OX™ portable medical oxygen cylinder has received a 2017 Innovative Technology designation from Vizient, Inc., the largest member-driven health care performance improvement company in the country. The designation was based on direct feedback from hospital representatives who interacted with the INTELLI-OX oxygen cylinder at the Vizient Innovative Technology Exchange in Denver. This is the first U.S. award received for the INTELLI-OX design.
The INTELLI-OX integrated medical oxygen cylinder features an advanced digital gauge to clearly and easily show the remaining time left at a given flow rate. It includes an integrated valve and regulator assembly, lightweight aluminum cylinder as well as visual and audible alerts when the cylinder is nearly empty and needs to be replaced. Measurements are provided in volume, pressure and time increments, simplifying readouts and eliminating guesswork for care providers.
Christophe Tardieu, Airgas Senior Vice President of Healthcare, Life Sciences and Specialty Gases, commented: “We’re proud to be recognized by Vizient for our innovative INTELLI-OX cylinder design. In addition to its proven reliability, our INTELLI-OX cylinders optimize the use of each cylinder to reduce turnover frequency.”
Debbie Archer, director of procurement and Vizient Innovative Technology Program leader, said: “Based on feedback from attendees at the Vizient Innovative Technology Exchange, it was determined INTELLI-OX should be recognized with an Innovative Technology designation. This designation will be noted in our online member contract catalog. Congratulations to Airgas Healthcare on receiving this status.”
The world leader in gases, technologies and services for Industry and Health, Air Liquide is present in 80 countries with approximately 65,000 employees and serves more than 3.5 million customers and patients. Oxygen, nitrogen and hydrogen are essential small molecules for life, matter and energy. They embody Air Liquide’s scientific territory and have been at the core of the company’s activities since its creation in 1902.
Air Liquide’s ambition is to lead its industry, deliver long term performance and contribute to sustainability. The company’s customer-centric transformation strategy aims at profitable growth over the long term. It relies on operational excellence, selective investments, open innovation and a network organization implemented by the Group worldwide. Through the commitment and inventiveness of its people, Air Liquide leverages energy and environment transition, changes in healthcare and digitization, and delivers greater value to all its stakeholders.
Air Liquide’s revenue amounted to € 20.3 billion in 2017 and its solutions that protect life and the environment represented more than 40% of sales. Air Liquide is listed on the Euronext Paris stock exchange (compartment A) and belongs to the CAC 40, EURO STOXX 50 and FTSE4Good indexes.